A. Di Biase et al., Susceptibility to oxidation of plasma low-density lipoprotein in X-linked adrenoleukodystrophy: Effects of simvastatin treatment, MOL GEN MET, 71(4), 2000, pp. 651-655
This paper shows for the first time the higher oxidizability of low-density
lipoprotein (LDL) in plasma from adrenoleukodystrophy (ALD) patients compa
red to that of control subjects. LDL oxidation susceptibility was assessed
by conjugate diene formation, hydroperoxide and lipoperoxide formation, and
electrophoretic mobility. Simvastatin therapy, an HMG-CoA reductase inhibi
tor, seems to be a protective pharmacological agent against the higher oxid
izability of LDL in plasma from ALD patients. (C) 2000 Academic Press.